Slone Partners appoints Amer Mirza, PhD as Chief Scientific Officer at Prolynx to strengthen R&D for its ultra‑long‑acting obesity therapeutics portfolio
Executive summary: Slone Partners named Amer Mirza, PhD, as Chief Scientific Officer at Prolynx, a company developing ultra‑long‑acting medicines for obesity and metabolic disorders. The hire adds senior scientific leadership to Prolynx’s R&D effort, potentially accelerating progress on its obesity drug pipeline in a competitive therapeutic area.
Who is involved: Slone Partners (executive search firm), Amer Mirza, PhD (appointee), Prolynx (biotechnology company).
Likely next: Prolynx is expected to advance its ultra‑long‑acting obesity programs under Mirza’s leadership, with further R&D updates anticipated later in 2026.
Slone Partners, a nationwide executive search firm focused on life sciences and healthcare, has placed Amer Mirza, PhD, as the new Chief Scientific Officer of Prolynx. The appointment is intended to drive the research and development execution of Prolynx’s pipeline of ultra‑long‑acting medicines targeting obesity and related metabolic conditions. No financial terms or additional details about Mirza’s compensation were disclosed in the announcement.
Timeline
- — Slone Partners Places Amer Mirza, PhD, as Chief Scientific Officer at Prolynx (PR Newswire)
- — Former Client and Three-Decade Data Sciences Leader John Reynders, PhD Joins Rancho BioSciences Leadership on Board of Directors (PR Newswire)
- — National Veterinary Associates Welcomes Laura Tortorella and Tina Hunt, PhD to Board of Directors (PR Newswire)
Analysis — what this means
Likely next events
- Prolynx anticipates accelerated R&D execution of its ultra‑long‑acting obesity medicines under the new CSO.
Sectors affected
- biotechnology
- obesity therapeutics
- executive search services
Historical parallels
- John Reynders, PhD appointed to Rancho BioSciences Board of Directors, July 14 2026
- Laura Tortorella, PhD and Tina Hunt, PhD appointed to National Veterinary Associates Board, July 9 2026
Key entities
Sources
- Slone Partners Places Amer Mirza, PhD, as Chief Scientific Officer at Prolynx — PR Newswire
- Former Client and Three-Decade Data Sciences Leader John Reynders, PhD Joins Rancho BioSciences Leadership on Board of Directors — PR Newswire
- National Veterinary Associates Welcomes Laura Tortorella and Tina Hunt, PhD to Board of Directors — PR Newswire